Besides the dose exculating trial, Astra Zenca has this compond in 3 other trials. Breast cancer and just recently they started a Prostrate trial and a trial in Japan for solid cancers. In June this year AT7519 enter a ph2 for Chronic Lymphotic Leukemia. AT13148 entered a trial in Advanced solid tumors with Cancer Research UK.
This is what is important to remember about ASTX, they have some very large companies in trials with partner compounds.